Peer-Reviewed Publications

Sum of the times cited: ISI1 6,290, Google Scholar2 8,839, Scopus3 6,241
Sum of Times cited without Self-Citations: ISI1 6,121, Scopus3 5,400
Average citations per item: ISI1 64.18
Quantified scientific research output (h-index): ISI1 36, Google Scholar2 42, Scopus3 35

  1. Elangovan R., Jenks M., Yun J., Dickson-Tetteh L., Lirtley S., Hemelaar J., and WHO-UNAIDS Network HIV Isolation and Characterisation. Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study. Frontiers in Microbiology 12: 690647 (doi:10.3389/fmicb.2021), 2021
  2. Chrysostomou A.C., Vrancken B., Koumbaris G., Themistokleous G., Aristokleous A., Masia C., Eleftheriou C., Ioannou C., Stylianou D.C., Ioannides M., Petrou P., Georgiou V., Hatziyianni A., Lemey P., Vandamme A-M., Patsalis P.P., and Kostrikis L.G. A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic. Viruses 13: 1098 (doi:10.3390/v13061098), 2021
  3. Hemelaar , Loganathan S., Elangovan R., Yun J., Dickson-Tetteh L., Kirtley S., and WHO-UNAIDS Network for HIV Isolation and Characterization. Country Level Diversity of the HIV-1 Pandemic between 1990 and 2015 J. Virol. 95(2), e01580-20 (doi: 10.1128/JVI.01580-20), 2021
  4. Quattrocchi A., Mamais I., Tsioutis C., Christaki E., Constantinou C., Koliou M., Pana Z.D., Silvestros V., Theophanous F., Charalambous C., Stylianou A., Sotiriou S., Athanasiadou M., Kyprianou T., Demetriou A., Demetriou A.C., Kolokotroni O., Gregoriou I., Pafitou N., Panos G., Kostrikis L.G., Karayiannis P., Petrikkos G., Agathaggelou P., Mixidis G., Siakallis G., Hadjihannas L., Palazis L., Vavlitou A., Matsentidou-Timilliotou H.,  Koukios D., Adamidi T., Frangopoulos F., Constantinou E., Nikolopoulos G. COVID-19 in the Republic of Cyprus: Successful Control with Public Health Interventions and Extended Testing Clin. Med., 2020, 9, 3598 (doi:10.3390/jcm9113598), 2020
  5. Chrysostomou A. and Kostrikis L.G. Methodologies of Primary HPV-Testing Currently Applied for Cervical Cancer Screening. Life 10(11), 290, 1-12 (doi:103390/life1010290), 2020
  6. Hemelaar J., Elangovan R., Yun J., Dickson-Tetteh L., Shona Kirtley S., Gouws-Williams E., Ghys P.D., and WHO-UNAIDS Network HIV Isolation. Global and Regional Epidemiology of HIV-1 Recombinants in 1990-2015: A systematic Review and Global Survey. The Lancet HIV. 7(11): e772-e781, 2020
  7. Chrysostomou A., Topcu C., Stylianou D.C., Hezka J. and Kostrikis L.G. Development of a Comprehensive Assay for the HIV-1 Genotypic Drug Resistance Testing for all Commercially Available Reverse Transcriptase, Protease and Integrase Inhibitors from Patients Infected with Group M HIV-1 strains. Infection, Genetics and Evolution, 81: 104243, 2020 (doi: 10.1016/j.meegid.2020.104243.), 2020
  8. Brown P., RELISH Consortium and Zhou Y. Large Expert-Curated Database for Benchmarking Document Similarity Detection in Biomedical Literature Search. Database, Vol. 2019:1-66 (Article ID baz085), 2019
  9. Stern Z., Stylianou D. C., and Kostrikis L.G. The Development of Inovirus-Associated Vector Vaccines Using Phage-Display Technologies. Expert Rev. Vaccines.  18(9): 913-920, 2019 (doi: 10.1080/14760584.2019.1651649.), 2019
  10. Paraskevis D., Stylianou D., Hezka J., Hezka J., Oikonomopoulou M., Mamais I., CYPRUS IVDU Network and Kostrikis L.G. HCV Phylogeography of the General Population and High-Risk Groups in Cyprus: A Global Sink for and Source of Viral Infection. Scientific Reports. 9(1): 10077 (doi: 10.1038/s41598-019-46552-7.), 2019
  11. Hemelaar J., Elangovan R., Yun J., Dickson-Tetteh L., Fleminger I., Kirtley S., Williams B., Gouws-Williams E., Ghys P.D., on behalf of WHO-UNAIDS Network for HIV Isolation Characterisation. Global and Regional Molecular Epidemiology of HIV-1, 1990-2015: A systematic Review, Global Survey, and Trend Analysis. Lancet Inf. Dis.  19(2): 143-155 (doi: 10.1016/S1473-3099(18)30647-9), 2019
  12. Chrysostomou A. C., Stylianou D. C., Constantinidou A., and Kostrikis L. G. Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing. Viruses 10(12): 729 (doi:10.3390/v10120729), 2018
  13. Kostrikis L. G., Hezka J., Stylianou D. C., Kostaki E. G., Andreou M., Kousiappa I., Paraskevis D. and Demetriades I. HIV-1 Transmission Networks Across Cyprus (2010-2012). PLoS One 13(4): e0195660, (doi: 10.1371/journal.pone.0195660), 2018
  14. Pineda-Peña A-C, Theys K., Stylianou D. C., Demetriades I., SPREAD/ESAR Program, Abecasis A. B. and Kostrikis L. G. HIV-1 Infection in Cyprus, the Eastern Mediterranean European Frontier: A Densely Sampled Transmission Dynamics Analysis from 1986 to 2012. Scientific Reports.  8(1): 1702 (doi: 10.1038/s41598-017-19080-5.), 2018
  15. Marshall A. D., Cunningham E. B., Nielsen S., Aghemo A., Alho H., Backmund M., Bruggmann P., Dalgard O., Seguin-Devaux C., Flisiak R., Foster G. R., Gheorghe L., Goldberg D., Goulis I., Hickman M., Hoffmann P., Jancorienė L., Jarcuska P., Kåberg M., Kostrikis L. G., Makara M., Maimets M., Marinho R. T., Matičič M., Norris S., Ólafsson S., Øvrehus A., Pawlotsky J-M., Pocock J., Robaeys G., Roncero C., Simonova M., Sperl J., Tait M., Tolmane I., Tomaselli S., van der Valk M., Vince A., Dore J. G., Lazarus J. V. and Grebely J. Restrictions for Reimbursement of Interferon-Free Direct-Acting Antiviral Therapies for HCV Infection in Europe. Lancet Gastroenterology & Hepatology. 3(2):125-133, (doi: 10.1016/S2468-1253(17)30284-4), 2018
  16. Vasou A., Sultanoglu N., Goodbourn S., Randall R. E. and Kostrikis L. G. Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: from Synthetic PRR Agonists to the potential of Defective Interfering Particles (DIPs) of Viruses. Viruses. 9(7): E186, (doi:10.3390/v9070186), 2017
  17. Oikonomopoulou M., Demetriou V., Kostrikis L.G. and Paraskevis D. Re-Analysis of Unassigned Hepatitis C Virus (HCV) Strain CYHCV025: Evidence of a Highly Divergent Lineage within Genotype 1. Mol. Phylogen. Evolution. 109: 362-366, 2017
  18. Magiorkinis G., Angelis K., Mamais I., Katzourakis A., Hatzakis A., Albert J., Lawyer G.,  Hamouda O., Struck D., Vercauteren J., Wensing A.M.J., Alexiev I., Åsjö B., Balotta C., Camacho R.J., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J.C., Sönnerborg A., Staneková D., Stanojevic M. and Boucher C.A.B. on behalf of the SPREAD program, Nikolopoulos G., Vasylyeva T., Friedman S.R., van de Vijver D.A.M.C., Angarano G., Chaix M-L., de Luca A., Korn K., Loveday C., Soriano V., Yerly S., Zazzi M.,  Vandamme A-M. and  Paraskevis D. The Global Spread of HIV-1 Subtype B Epidemic. Inf. Gen. Evolution S1567-1348 (16): 30223-4, 2016
  19. Hofstra L.M., Sauvageot N., Albert J., Alexiev I., Garcia F., Struck D., van de Vijver D.A.M.C., Asjo B., Beshkov D., Coughlan S., Descamps D., Griskevicious A., Hamouda O., Horban A., van Karsteen M., Kolupajeva T., Kostrikis L.G., Liitsola K., Linka M., Mor O., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stockl E., Sonnerborg A., Stanekova D., Stanojevic M., Vandamme A-K., Zazzi M., Zidovec Lepej S., Boucher C.A.B., Schmit J-C., and Wensing A.M.J. on behalf of the SPREAD Program. Transmission of HIV Drug Resistance Mutations and Their Predicted Effect on Current First Line Regimens in Europe. Clin. Inf. Dis. 62(5): 655-663, 2016
  20. Casadella M., van Ham P. M., Noguera-Julian M., van Kessel A., Pou C., Hofstra L.M., Santos J.R., Garcia F., Struck D., Alexiev I., Asjo B., Hoepelman A.I., Kostrikis L.G., Kucherer C., Liitsola K., Linka M., Nielsen C., Otelea D., Paraskevis D., Poljak M., Puchhammer-Stockl E., Stranekova D., Stanojevic M., Vandamme A.M., Zidovec Lepej S., Clotet B., Boucher C.A.B., Wensing A.M.J., on behalf of the SPREAD Programme. Primary Resistance to Integrase Strand-Transfer Inhibitors in Europe. J. Antim. Chemotherapy 70: 2885-2888, 2015
  21. Mamais I., Albert J., Angelis K., Magiorkinis G., Hatzakis A., Hamouda O., Struck D., Vercauteren J., Wensing A.M.J., Alexiev I., Åsjö B., Balotta C., Camacho R.J., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kostrikis L.G., Lepej S. J., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J.C., Sönnerborg A., Staneková D., Stanojevic M. and Boucher C.A.B., Vandamme A-M and  Paraskevis D. Global Dispersal Patterns of HIV-1 CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Activities Centralized in South-East Asia J. Inf. Diseases 211(11): 1735-1744, 2015
  22. Hasapis K., Stylianou D. and Kostrikis K. Architectural Insight Into Inovirus-Associated Vectors (IAVs) and Development of IAV-Based Vaccines Inducing Humoral and Cellular Responses: Implications in HIV-1 Vaccines. Viruses 6(12): 5047-5076, 2014
  23. Wiessing L., Ferri M., Grady B., Kantzanou M., Sperle I., Cullen K. J., EMCDDA DRID group, Hatzakis A., Prins M., Vickerman P., Lazarus J. V., Hope V. D. and Mathei C. Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A systematic Review of Data for Scaling Up Treatment and Prevention. PloS One 9(7) e103345, 2014
  24. Frentz D., van de Vijver D.A.M.C., Abecasis A.B.,  Albert J., Hamouda O., Jorgensen L. B., Kücherer C., Struck D., Schmit J.-C., Vercauteren J., Asjö B., Balotta C., Beshkov D., Camacho R.J., Clotet B., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kolupajeva T., Korn K., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E.,  Sönnerborg A., Stanekova D., Stanojevic M., Wijngaerden E. V., Wensing A. M. J., Boucher C.A.B. and on behalf of the SPREAD Programme. Increase in Transmitted Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors among Newly Diagnosed HIV-1 Infections in Europe. BMC Inf. Diseases 14:407 doi:10.1186/1471-2334-14-407, 2014
  25. Pineda-Peña A-C., Schrooten Y., Vinken L., Ferreira F., Li G., Trovão N. S., Khouri R., Derdelinckx I., de Munter P., Kücherer C., Kostrikis L. G., Nielsen C., Littsola K., Wensing A., Stanojevic M., Paredes R., Balotta C., Albert J., Boucher C., Gomez-Lopez A., van Wijngaerden E., van Ranst M., Vercauteren J., Vandamme A-M. and van Laethem K. Trends and Predictors of Transmitted Drug Resistance (TDR) and TDR Clusters in a Local Belgian HIV-1 Epidemic. PloS One 9(7) e101738, 2014
  26. Frentz D., van de Vijver D.A.M.C., Abecasis A.B.,  Albert J., Hamouda O., Kücherer C., Struck D., Schmit J.-C., Vercauteren J., Asjö B., Balotta C., Beshkov D., Camacho R.J., Clotet B., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kolupajeva T., Korn K., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paraskevis D., Paredes R., Poljak M., Puchhammer-Stöckl E.,  Sönnerborg A., Stanekova D., Stanojevic M., Vandamme A.-M., Boucher C.A.B. and Wensing A. M. J. on behalf of the SPREAD Programme. Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group. PLoS One 9(4) e94495, 2014
  27. Antoniadou Z-A., Kousiappa I., Skoura L., Pilalas D., Metallidis S., Nicolaidis P., Malisiovas N. and Kostrikis L. G. Molecular Epidemiology of HIV-1 Infection in Northern Greece (2009-2010): Evidence of a Transmission Cluster of HIV-1 Subtype A1 Drug Resistant Strains Among Men Having Sex with Men. AIDS Res. Hum. Retrov. 30(3): 225-232, 2014
  28. Antoniadou Z-A., Hezka J., Kousiappa I., Mamais I., Skoura L., Pilalas D., Metallidis S., Nicolaidis P., Malisiovas N. and Kostrikis L. G. Cellular HIV-1 DNA Levels Are Equivalent Among Drug Sensitive and Drug Resistant Strains in Newly Diagnosed and Antiretroviral Naive Patients. AIDS Res. Hum. Retrov. 30(3): 266-271, 2014
  29. Hassapis K. A. and Kostrikis L. G. HIV-1 Vaccine Strategies Utilizing Viral Vectors Including Antigen-Displayed Inoviral Vectors. Current HIV Research 11:610-622, 2013
  30. Frentz D., Wensing A.M.J., Albert J., Paraskevis D., Abecasis A.B., Hamouda O., Jørgensen L.B., Kücherer C., Struck D., Schmit J.-C., Vercauteren J., Åsjö B., Balotta C., Beshkov D., Camacho R.J., Clotet B., Coughlan S., Griskevicius A., Grossman Z., Horban A., Kolupajeva T., Korn K., Kostrikis L.G., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E.,  Sönnerborg A., Stanekova D., Stanojevic M., Vandamme A.M., Boucher C.A.B., and Van de Vijver D.A.M.C. on behalf of the SPREAD Programme. Limited Cross-Border Infections in Patients Newly Diagnosed with HIV in Europe. Retrovirology 10:36, 2013
  31. Abecasis A.B., Wensing A.M.J, Paraskevis D., Vercauteren J., Theys K., Van de Vijver D.A.M.C., Albert J., Asjö B., Balotta C., Beshkov D., Camacho R.J., Clotet B., Coughlan S., Griskevicius A., Grossman Z., Hamouda O., Horban A., Kolupajeva T., Korn K., Kostrikis L.G., Kücherer C., Liitsola K., Linka M., Nielsen C., Otelea D., Paredes R., Poljak M., Puchhammer-Stöckl E., Schmit J-C., Sönnerborg A., Stanekova D., Stanojevic M., Struck D., Boucher C.A.B. and Vandamme A-M. HIV-1 Subtype Distribution and its Demographic Determinants in Newly Diagnosed Patients in Europe Suggest Highly Compartmentalized Epidemics. Retrovirology 10:7, 2013
  32. Theys, K., Deforche, K., Vercauteren, J., Libin, P., van de Vijver, D. A., Albert, J., Asjo, B., Balotta, C., Bruckova, M., Camacho, R. J., Clotet, B., Coughlan, S., Grossman, Z., Hamouda, O., Horban, A., Korn, K., Kostrikis, L. G., Kucherer, C., Nielsen, C., Paraskevis, D., Poljak, M., Puchhammer-Stockl, E., Riva, C., Ruiz, L., Liitsola, K., Schmit, J. C., Schuurman, R., Sonnerborg, A., Stanekova, D., Stanojevic, M., Struck, D., van Laethem, K., Wensing, A. M., Boucher, C. A., and Vandamme, A. M. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients, Retrovirology 9(1):81, 2012
  33. Demetriou L. V., Kyriakou E., and Kostrikis L. G. Near-Full Characterization of Two Natural Intergenotypic 2k/1b Recombinant Hepatis C Virus Isolates. Advances in Virology, Vol. 2011, Article ID 710438, 6 pages, doi:10.1155/2011/710438, 2011
  34. Demetriou V., and Kostrikis L. G. Near-Full Genome Characterization of Unclassified Hepatitis C Virus Strains Relating to Genotypes 1 and 4 . Med. Virol. 83(12): 2119-2127, 2011
  35. Kousiappa I., Achilleos C., Hezka J., Lazarou Y., Othonos K., Demetriades I. and Kostrikis L. G. Molecular Characterization of HIV-1 Strains from Newly Diagnosed Patients in Cyprus (2007-2009) Recovers Multiple Clades Including Recombinant Strains and Lack of Transmitted Drug Resistance. AIDS Res. Hum. Retrov. 27(11): 1183-1199, 2011
  36. Vandekerckhove L.P.R., Wensing A. M. J., Kaiser R., Brun_vezinet F., Clotet B., De Luca A., Dressler S., Garcia., Geretti A. M., Klimkait T., Korn K., Masquelier B., Perno, C. F., Schapiro J. M., Soriano V., Vandamme A-M., Verhofstede C., Walter H. Zazzi, M., Boucher C. A. B., Puchhammer-Stockl, E., Van Laethem K., Ivanov I., Beshkov D., Lepej S. Z., Kostrikis L. G., Linka M., Nielsen C., Zilmer K., Liitsola K., Braun P., Daeumer M., Obermeier M., Paraskevis D., Minarovits J., Coughlin S., De Gascun C., Grossman Z., Balotta C., Rusconi S., Svicher V., Kolupajeva T., Griskevicius A., Schmit J-C., Schuurman R., Asjo B., Horban A., Camacho R., Ene L., Otelea D., Stanojevic, M., Stanekova D., Poljak M., Paredes R., Poveda E., Albert J., Yerly, S., Cane P., and Pillay, Deenan. European Guidelines on the Clinical Management of HIV-1 Tropism Testing. Lancet Inf. Diseases. 11(5): 394-407, 2011
  37. Hadjinicolaou A., Fargas G., Demetriou V. L., Mazzulli T., Poutanen S., Willey B., Low E. D., Butany J., Asa L. S., Kain K., and Kostrikis L. G. Development of a Molecular-Beacon-Based Multiallelic Real-Time RT-PCR Assay for the Detection of Human Coronavirus Causing Severe Acute Respiratory Syndrome (SARS-CoV): A General Methodology for Detecting Rapidly Mutating Viruses. Archives of Virology 156:671-680, 2011
  38. Demetriou L, van de Vijver D. A. M. C., Kousiappa I., Balotta C., Clotet B., Grossman Z., Jørgensen L. B., Lepej S. Z., Levy I., Nielsen C., Paraskevis D., Poljak M., Roman F., Ruiz L., Schmidt J-C., Vandamme A-M., Van Laethem K., Vercauteren J. and Kostrikis L.G. Cellular HIV-1 DNA Levels in Drug Sensitive Strains Are Equivalent to Those in Drug Resistant Strains in Newly-Diagnosed Patients in Europe. PLoS One 5(6) e10976, 2010
  39. Demetriou V., Van de Vijver D. A. M. C., Hezka J. The Cyprus IVDU Network and Kostrikis L. G. Hepatitis C Infection among Intravenous Drug Users Attending Therapy Programmes in Cyprus. Journal of Medical Virology. 82 (2): 263-270, 2010
  40. Demetriou L. V., The Cyprus HCV Network and Kostrikis L. G. Molecular Epidemiology of Hepatitis C Infection in Cyprus within the General Population and High-Risk Groups. BMC Res. Notes 24:468 doi: 10.1186/1756-0500-4-468, 2011
  41. Vercauteren J., Wensing M. J., van de Vijver D. A. M. C., Albert J., Balotta C., Hamouda O., Kücherer C., Struck D., Schmit J. C., Asjo B., Bruckova M., Camacho R., Clotet B., Coughlan S., Grossman Z., Horban A., Korn K., Kostrikis L. G., Nielsen C., Paraskevis D., Poljak M., Puchhammer-Stockl E., Riva C., Ruiz L., Salminen M., Schuurman R., Sonnerborg A., Stanekova D., Stanojevic M., Vandamme A. M., and Boucher C. A. B. on behalf of the SPREAD-programme. Transmission of Drug Resistant HIV is Stabilizing in Europe. Journal of Infectious Diseases. 200 (10): 1503-1508, 2009
  42. Kousiappa I., Demetriades I., Kostrikis L. G. Near Full-Length Genetic Analysis of HIV-1 Sequences Derived from Cyprus: Evidence of a Highly Polyphyletic and Evolving Infection. AIDS Res. Hum. Retrov. 25(8): 727-740, 2009
  43. Loizidou E., Zeinalipour-Yazdi C., Christophides T., and Kostrikis L. G. Analysis of Binding Parameters of HIV-1 Integrase Inhibitors: Correlates of Drug Inhibition and Resistance. Bioorganic and Med. Chem. 17: 4806-4818, 2009
  44. Hadjinicolaou A., Demetriou V., Hezka J., Wolfgang B., Hadfield L. T. and Kostrikis L. Use of Molecular Beacons and Multi-Allelic Real-Time PCR for Detection of and Discrimination between Virulent Bacillus anthracis and other Bacillus Journal of Microbiological Methods 78: 45-53, 2009
  45. Hadjinicolaou A., Demetriou L. V., Emanouel M., Kakoyiannis C. and Kostrikis L. G. Molecular Beacon-Based Real-Time PCR Detection of Primary Isolates of Salmonella Typhimurium and Salmonella Enteritidis in Environmental and Clinical Samples. BMC Microbiology. 9: 97-110, 2009
  46. Demetriou L. V., van de Vijver D. A. M. C., The Cyprus HCV Network and Kostrikis L. G. Molecular Epidemiology of Hepatitis C Infection in Cyprus: Evidence of Polyphyletic Infection. Med. Virol. 81: 238-248, 2009
  47. Loizidou E., Kousiappa I., Zeinalipour-Yazdi C. D., van de Vijver D. A. M. C. and Kostrikis L. G. Implications of HIV-1 M-Group Polymorphisms on Integrase Inhibitor Efficacy and Resistance: Genetic and Structural in-silico Biochemistry 48(1): 4-6, 2009
  48. Kousiappa I, Van der Vijver D., Demetriades I., Kostrikis L. G. Genetic Analysis of HIV Type 1 Strains from Newly Infected Untreated Patients in Cyprus: High Genetic Diversity and Low Prevalence of Drug Resistance. AIDS Res. Hum. Retrov. 25(1):23-35, 2009
  49. Heyman P., Vaheri A., the ENIVD members. Situation of Hantavirus Infections and Haemorragic Fever with Renal Syndrome in European Countries as of December 2006. Eurosurveillance 13:1-7, 2008
  50. Zeinalipour-Loizidou E., Nicolaou C., Nicolaides A., Kostrikis L. G. HIV-1 Integrase: From Biology to Chemotherapeutics. Current HIV Research 5:365-388, 2007
  51. Anastassopoulou C., Kostrikis L. G. Global Genetic Variation of HIV-1 Infection. Current HIV Research 4:365-373, 2006
  52. Anastassopoulou C., Kostrikis L. G. Viral Correlates of HIV-1 Disease. Current HIV Research 3:113-132, 2005
  53. Hatzakis A., Touloumi G., Karanicolas R., Pantazis N., Anastassopoulou C., Katsarou O., Karafoulidou A., Goedert J. J., Kostrikis L. G. Cellular HIV-1 DNA Load Predicts HIV-RNA Rebound and the Outcome of Highly Active Antiretroviral Therapy. AIDS 18(17): 2261-2267, 2004
  54. Touloumi G., Pantazis N., Karafoulidou , Mandalaki T., Goedert J. J., Kostrikis L. G., Hatzakis A. Changes in T-cell Receptor Excision (TREC) Levels in HIV-1-Infected Subjects Pre- and Post-Highly Active Antiretroviral Therapy AIDS Res. Hum. Retrov. 20(1): 47-54, 2004
  55. Metzner J., Bonhoeffer S., Fischer M., Karanicolas R., Allers K., Joos B., Weber R., Hirschel B., Kostrikis L. G. Gunthard H. Emergence of Minor Populations of Human Immunodefieciency Virus Type 1 Carrying the M184V and L90M Mutations in Subjects Undergoing Structured Treatment Interruptions. J. Infect. Dis. 188(10): 1433-1443, 2003
  56. Anastassopoulou C., Kostrikis L. G. The Impact of Human Allelic Variation on HIV-1 Disease. Current HIV Research 1:185-203, 2003
  57. Schweighardt B., Ortiz G. M., Grant R. M., Wellons M., Montefiori , Miralles G. D., Kostrikis L. G., Bartlett J. A., Nixon D. F. Emergence of Drug Resistant Variants in Subjects Undergoing Structured Treatment Interruptions AIDS 16 (17): 2342-2343, 2002
  58. Kostrikis L. G., Touloumi G., Karanicolas R., Pantazis N., Anastassopoulou C., Karafoulidou A., Goedert J. J., Hatzakis A. Quantitation of Human Immunodeficiency Virus Type I DNA Forms with the Second Template Switch in Peripheral Blood Predicts Disease Progression Independently of Plasma RNA Load. Virol. 76 (20): 10099-10108, 2002
  59. Petridou E., Klimentopoulou M., Kostrikis L. G., Hatzakis A., Trichopoulos D., and the Childhood Hematology Oncology Group. Recent Thymic Emigrants in T- and B-Cell Childhood Hematopoietic Malignacies. J. Cancer 101 (1): 74-77, 2002
  60. Valentin A., Rosati M., Patenaude D. J., Hatzakis A., Kostrikis L.G., Lazanas M., Wyvill K. M., Yarchoan R., Pavlakis G. N. Persistent HIV-1 Infection of Natural Killer Cells in Patients Receiving Highly Active Anti-Retroviral Therapy. Natl. Acad. Sci. USA 99 (10): 7015-7020, 2002
  61. Goedert J. J., O’Brien T. R., Hatzakis A., Kostrikis L. G., and the Multicenter Hemophilia Cohort Study. T-Cell Receptor Excision Circles and HIV-1 2LTR Episomal DNA to Predict AIDS in Patients not Receiving Effective Therapy. AIDS. 15 (17): 2245-2250, 2001
  62. Ioannidis J. P. A., Rosenberg P. S., Goedert J. J., Ashton L. J., Benfield T. L., Buchbinder S. P., Coutinho R. A., Eugen-Olsen J., Gallart T., Katzenstein T. L., Kostrikis L. G., Kuipers H., Louie L., Mallal S.A., Margolick J. B., Martinez O. P., Meyer L., Michael N. L., Operskalski E., Pantaleo G., Rizzardi P. G., Schuitemaker H., Sheppard H. W., Stewart G. J., Theodorou I. D., Ullum H., Vicenzi E., Vlahov D., Wilkinson D., Workman C., Zagurdy J-F., O’Brien T. R. for the International Meta-Analysis of HIV Host Genetics. Effects of CCR5-32, CCR2-64I and SDF-1 3’A polymorphisms on HIV disease progression: An international meta-analysis. Intern. Med. 135 (9): 782-795, 2001.
  63. John G. C, Bird T., Overbaugh J., Nduati R., Mbori-Ngacha D., Rostron T., Dong T., Kostrikis L G., Richardson B., Rowland-Jones S. L. CCR5 Promoter Polymorphisms in a Kenyan Perinatal Human Immunodeficiency Virus Type 1 Cohort: Association with Increased 2-year Maternal Mortality. Infect. Dis. 184 (1): 89-92, 2001.
  64. Gao F., Vidal N., Li Y., Trask S. A., Chen Y., Kostrikis L. G., Ho D. D., Oh M-D., Salminen M., Robertson D. L., Shaw G. M., Hahn B. H., Peeters M. Evidence for Two Distinct Sub-subtypes within the HIV-1 Subtype A Radiation. AIDS Res. Hum. Retrov. 17 (8): 675-688, 2001.
  65. Sriwanthana B., Hodge T., Mastro D. T., Dezzutti C. S., Bond K., Stephens H. A. F., Kostrikis L. G., Limpakarnjanarat K., Young N. L., Qari S. H., Lal R. B., Chandanayingyong D., McNickoll J. M. HIV-Specific Cytotoxic T Lymphocytes, HLA-A11, and Chemokine Related Factors May Act Synergistically to Determine HIV Resistance in CCR5 32 Negative Female Sex Workers in Chiang Rai, Northern Thailand. AIDS Res. Hum. Retrov. 17 (8): 719-734, 2001.
  66. Barbouche R. M., Hong L., Dellagi K., Kostrikis L. G. Contrasting Frequencies of CCR5D32 and CCR2-64I Alleles In the Tunisian Population. Acq. Immun. Def. Synd. 26 (3): 298-299,  2001
  67. Paraskevis D., Magiorkinis M., Vandamme A. M., Kostrikis L. G., Hatzakis A. Re-Analysis of Human Immunodeficiency Virus Type 1 Isolates from Cyprus and Greece Initially Designed as ‘Subtype I’ Revealed a Unique Complex A/G/H/K Mosaic Pattern. Gen. Virol. 82: 575-580, 2001.
  68. Maayan S., Zhang L., Shinar E., Ho J., He T., Manni N., Kostrikis L. G., Neumann A. U. Evidence for Recent Selection for the CCR5-Δ32 Deletion from Differences in its Frequency Between Ashkenezi and Sephardim Jews. Genes Immun. 1 (6): 358-361, 2000.
  69. Metzner, K. J., Jin X., Lee F. V., Gettie A., Bauer E. D., Di Mascio M., Perelson A. S., Marx P. A., Ho D. D., Kostrikis L. G., Connor R. I. Effects of in vivo CD8+ T cell Depletion on Virus Replication in Rhesus macaques Immunized with a Live, Attenuated SIV Vaccine. Exp. Med. 191 (11): 1921-1931, 2000.
  70. Kostrikis L. G. Impact of Natural Chemokine Receptor Polymorphisms on Perinatal Transmission of Human Immunodeficiency Virus Type 1. Teratology 61 (5): 387-390, 2000.
  71. Valentin A, Trivedi H., Lu W., Kostrikis L. G., Pavlakis G. N. CXCR4 Mediates Entry and Productive Infection of Syncytia-Inducing (X4) HIV-1 Strains in Primary Macrophages. Virology 269 (2): 294-304, 2000.
  72. Martinson J. J., Hong L., Karanicolas R., Moore J. P., Kostrikis L. G. Global Distribution of the CCR2-64I/CCR5-59356T HIV-1 Disease-Protective Haplotype. AIDS 14 (5): 483-489, 2000.
  73. Hatzakis A., Touloumi G., Karanicolas R., Anastassopoupou C., Karafoulidou A., Mandalaki T., Goedert J. J., Zhang L., Ho D. D., Kostrikis L. G. Effect of Recent Thymic Emigrants on Progression of HIV-1 Disease. Lancet 355 (9204): 599-604, 2000.
  74. Sharkey M., Teo I., Greenough T., Sharova N., Luzuriaga K., Sullivan J. L., Bucy P., Kostrikis L. G., Davaro R., Cheeseman S., Daly J., Bova C., Ellison D., Mady B., Lai K. K., Moyle G., Nelson M., Gazzard B., Shaunak S., Stevenson M. Persistense of Episomal HIV-1 Infection Intermediates in Patients on Active Anti-Retroviral Therapy. Med. 6 (1): 76-81, 2000.
  75. Kostrikis, L. G., Neumann A. U., Thomson B., Korber T. B., McHarty P. G., Karanicolas R., Deutsch L., Huang Y., Lew J. F., Mcintosh K., Pollack H., Borkowsky W., Spiegel H. M. L., Palumbo P., Oleske J., Bardequez A., Luzuriaga K., Sullivan L. J., Wolinsky S. M., Koup R. A., Ho D. D., Moore J. P. A Polymorphism in the Regulatory Regions of the CC-Chemokine Receptor 5 Gene Influences Perinatal Transmission of Human Immunodeficiency Virus Type 1 to African-American Infants. Virol. 73 (12): 10264-10271, 1999.
  76. Zhang, L., Lewin S., Markowitz M., Lin H-H., Skulsky E., Karanicolas R., He Y., Jin X., Tuttleton S., Vesamen M., Spiegel H., Kost R., Wolinsky S., Borkowsky W., Palumbo P., Kostrikis L. G., Ho D. D. Measuring Recent Thymic Emigrants in Blood of Normal Persons and HIV-1-Infected Patients Before and After Effective Therapy. Exp. Med. 190 (5): 725-732, 1999.
  77. Lewin S. R., Vesamen M., Kostrikis L. G., Hurley A., Duran M., Zhang L., Ho D. D., Markowitz M. The Use of Real-Time PCR and Molecular Beacons to Detect Virus Replication in HIV-1-Infected Individuals on Prolonged Effective Antiretroviral Therapy. Virol. 73 (7): 6099-6103, 1999.
  78. Jin, X., Bauer D. E., Tuttleton S. E., Lewin S., Gettie A., Kostrikis L. G., Blanchard J., Irwin C. E., Safrit J. T., Zhang L., Ho D. D. Dramatic Rise in the Plasma Viremia after CD8+ T-cell Depletion in SIV-Infected macaques. Exp. Med. 189 (12): 991-998, 1999.
  79. Robbins, K. E., Kostrikis L. G., Brown T. M., Anzala O., Shin S., Plummer F. A., Ho D. D., Kalish M. L. Genetic Analysis of Human Immunodefiency Virus Type 1 Strains in Kenya: A Comparison Using Phylogenetic Analysis and a Combinatorial Melting Assay (COMA). AIDS Res. Hum. Retrov. 15 (4): 329-335, 1999
  80. Gao F., Robertson D. L., Carruthers C. D., Li Y., Bailes, E., Kostrikis L. G., Salminen M. O., Bibollet-Ruche F., Peeters M., Ho D. D., Shaw P. M., Sharp P. M., Hahn B. H. An Isolate of Human Immunodeficiency Virus Type 1 Originally Classified as Subtype I Represents a Complex Mosaic Comprising Three Different Group M Subtypes (A, G, and I). Virol. 72 (12): 10234-10241, 1998.
  81. Zhang Y-J., Dragic T., Cao Y., Kostrikis G. L., Kwon S. D., Littman R. D., Kenal-Ramani N. V., Moore J.P. Use of Co receptors Other Than CCR5 or CXCR4 by Adult and Pediatric Isolates of Human Immunodeficiency Virus Is Rare in vitro. Virol. 72 (11): 9337-9344, 1998.
  82. Kostrikis L. G., Shin S., Ho D. D. Genotyping HIV-1 and HCV Strains by a Combinatorial DNA Melting Assay (COMA). Med. 4 (7): 443-453, 1998.
  83. Kostrikis L. G., Huang Y., Moore J. P., Wolinsky S. M., Zhang L., Guo Y., Deutsch L., Phair J., Neumann A. U., Ho D. D. A Chemokine Receptor CCR2 Allele Delays HIV-1 Disease Progression and is Associated with a CCR5 Promoter Mutation. Med. 4 (3): 350-353, 1998.
  84. Kostrikis L. G., Tyagi S., Mhlanga M., Ho D. D., Kramer R. F. Spectral Genotyping of Human Alleles. Science 279 (5354): 1228-1229, 1998.
  85. Christodoulou C., Poullikas M, Neumann U. A., Kostrikis G. L. Low Frequency of CCR5D32 Allele Among Greeks in Cyprus. AIDS Res. Hum. Retrov. 13 (16): 1373-1374, 1997.
  86. Kostrikis L. G., Michalopoulou Z-H, Cao Y., Moore J. P., Ho D. D. Determining Neutralization Serotypes of HIV-1 by Neural Networks. AIDS Res. Hum. Retrov. 12 (18): 1667-1669, 1996.
  87. Kostrikis L. G., Cao Y., Ngai H., Moore J. P., Ho D. D. Quantitative Analysis of Serum Neutralization of Human Immunodeficiency Virus Type 1 from Subtypes A, B, C, D, F, and I: Lack of Direct Correlation Between Neutralization Serotypes and Genetic Subtypes and Evidence for Prevalent Serum-Dependent Infectivity Enhancement. Virol. 70 (1): 445-458, 1996.
  88. Kostrikis L. G., Bagdades E., Cao Y., Zhang L., Dimitriou D., Ho D. D. Genetic Analysis of Human Immunodeficiency Virus Type-1 Strains from Patients in Cyprus: Identification of a New Subtype (I). Virol. 69 (10): 6122-6130, 1995.
  89. Kostrikis L. G., Reisberg S. A., Kim H. Y., Day L. A. C2, an Unusual Filamentous Bacterial Virus: Protein Sequence and Conformation, DNA size and Conformation, and Nucleotide/Subunit Ratio. Biochemistry 34 (12): 4077-4087, 1995.
  90. Kostrikis L. G., Liu D. J., Day L. A. Ultraviolet Absorbance and Circular Dichroism of Pf1virus: Nucleotide/Subunit Ratio of Unity, Hyperchromic Tyrosines and DNA Bases, and High Helicity in the Subunits. Biochemistry 33 (7): 1694-1703, 1994
  91. Kostrikis L. G., Reisberg S. A., Simon M. N., Wall J. S., Day L. A. Export of Infectious Particles by Escherichia coli Transfected with the RF DNA of Pf1, a Virus of Pseudomonas aeruginosa strain K. Microbiol. 5 (11): 2641- 2647, 1991.

1 Provided by The Institute for Scientific Information (ISI® ); Web of Science Researcher ID: A-5330-2016; updated September 2, 2021. Quantified scientific research output (h-index) was calculated based on algorithm provided by J.E. Hirsch (Hirsch J.E. An index to quantify an individual’s scientific research output. Proc. Natl. Acad. Sci. U. S. A. 102(46):16569-72, 2005); updated September 2, 2021

2 Provided by Google Scholar; Google Scholar ID: 7zmZXAUAAAAJ; updated September 2, 2021

3 Provided by Scopus®; Author ID: 6701410435; updated September 2, 2021